Hoppa till innehåll

  • Hem
  • Om oss
    • Om oss
    • Historik
    • Styrelse
    • Medarbetare
    • Reuma Direkt
  • Projekt
  • PUBLIKATIONER
    • Vetenskapliga artiklar
      • 2024
      • 2023
      • 2022
      • 2021
      • 2020
      • 2019
      • 2018
      • 2017
      • 2016
      • 2015
      • 2014
      • 2013
      • 2012
      • 2011
      • 2010
    • Konferensabstrakt
      • EULAR 2020
      • EULAR 2019
      • EULAR 2018
      • EULAR 2017
      • ACR 2015
      • ACR 2014
      • ACR 2013
      • EULAR 2013
      • HPH-konferens 2013
      • ACR 2012
      • EULAR 2012
      • Medicinska Riksstämman 2012
    • Doktorsavhandlingar
    • Populärvetenskap
  • Nyheter
  • Kontakt
Publicerat 24-jan-202224-jan-2022 av Henrik Karlsson

High survivin levels predict poor clinical response to infliximab treatment in patients with rheumatoid arthritis.

Isgren A, Forslind K, Erlandsson M, Axelsson C, Andersson S, Lund A, Bokarewa M. Semin Arthritis Rheum. 2012 Apr;41(5):652-7.

Kategorier2012, Kristina Forslind, Publikationer

Inläggsnavigering

Föregående inläggFöregående Föregående inlägg
Nästa inläggNästa Nästa inlägg
Drivs med WordPress
Cookie modal illustration
Our cookies
This site uses cookies necessary for its proper functioning. You can accept them all or click on “learn more” to choose which cookies you accept or not.
Read the privacy policy
powered by webdeclic
Cookie modal illustration
Our cookies
Here is the list of cookies necessary for the proper functioning of the site, you cannot deactivate them but we must tell you about them.
powered by webdeclic
Cookie modal illustration
Our cookies
On this site, we use cookies in order to analyze our traffic, maintain a quality relationship with you and occasionally offer you relevant content. You can choose here which ones you agree to keep.
powered by webdeclic